• A persistent cough and fever have been confirmed as the most prevalent symptoms associated with COVID-19 according to the new international research
  • Data analysed from over 24,000 patients from nine countries including the UK, China and the US
  • University of Sheffield medical student helped conduct the study, which is one of the biggest reviews (or meta data analysis) into COVID-19 symptoms 

Newswise — A persistent cough and fever have been confirmed as the most prevalent symptoms associated with COVID-19, according to a major international review of patient data.

Other major symptoms include fatigue, losing the ability to smell and difficulty in breathing.  

The study ratifies the list of symptoms compiled by the World Health Organisation at the start of the pandemic.

A team of researchers including a final year medical student from the University of Sheffield combined data from 148 separate studies, to identify the common symptoms experienced by more than 24,000 patients from nine countries including the UK, China and the US. 

The study - published in the online journal PLoS One - is one of the biggest reviews, or meta analysis, ever conducted into COVID-19 symptoms. 

Of the 24,410 cases, the study found:

*78 per cent had a fever. Although this tended to vary across countries, with 72 per cent of fever reported by patients in Singapore and 32 per cent in Korea.

*57 per cent reported a cough. Again, this varied across countries, with 76 per cent of patients reporting a cough in the Netherlands compared to 18 per cent in Korea. 

*31 per cent said they had suffered fatigue. 

*25 per cent lost the ability to smell. 

*23 per cent reported difficulty breathing. 

The researchers believe the variation in the prevalence of symptoms between countries is due, in part, to the way data was collected. 

Of those patients who needed hospital treatment, 17 per cent needed non-invasive ventilation; 19 per cent had to be looked after in an intensive care unit, nine per cent required invasive ventilation and two per cent needed extracorporeal membrane oxygenation (an artificial lung). 

Michael Grant, a final year medical student from the University of Sheffield, said: “The impact of COVID-19 on daily activities has been immense. 

“An accurate estimation of symptom prevalence, as provided by this study, is essential to combat COVID-19”

“As a medical student, it has been a tremendous opportunity and a great privilege to contribute to research that will be used to inform public health opinion.”

Mr Ryckie Wade, a surgeon and Clinical Research Fellow at the Leeds Institute of Medical Research, who supervised the research, said: "This analysis confirms that a cough and fever were the most common symptoms in people who tested positive with COVID-19.

"This is important because it ensures that people who are symptomatic can be quarantined. 

"The study gives confidence to the fact that we have been right in identifying the main symptoms and it can help determine who should get tested." 

The study involved academics from the University of Leeds with colleagues from the University of Sheffield, University of Bristol, Imperial College, London, and the Belgium Cancer Centre. The research was funded by the UK's National Institute for Health Research and VALCOR, in Belgium. The researchers acknowledge there are people who had the virus but did not display any symptoms.

Additional information 

The University of Sheffield’s Medical School trains world class clinical and researchers who prolong and improve lives everyday.

The vision of the Medical School is to achieve research excellence and impact by translating scientific discoveries into meaningful advances that can benefit patients and the general population. This vision is supported by competitive funding from major national and international research bodies including Government, Research Councils, industry and charities.  
For more information please visit: https://www.sheffield.ac.uk/medicine

The University of Sheffield

With almost 29,000 of the brightest students from over 140 countries, learning alongside over 1,200 of the best academics from across the globe, the University of Sheffield is one of the world’s leading universities.

A member of the UK’s prestigious Russell Group of leading research-led institutions, Sheffield offers world-class teaching and research excellence across a wide range of disciplines.

Unified by the power of discovery and understanding, staff and students at the university are committed to finding new ways to transform the world we live in.

Sheffield is the only university to feature in The Sunday Times 100 Best Not-For-Profit Organisations to Work For 2018 and for the last eight years has been ranked in the top five UK universities for Student Satisfaction by Times Higher Education.

Sheffield has six Nobel Prize winners among former staff and students and its alumni go on to hold positions of great responsibility and influence all over the world, making significant contributions in their chosen fields.

Global research partners and clients include Boeing, Rolls-Royce, Unilever, AstraZeneca, Glaxo SmithKline, Siemens and Airbus, as well as many UK and overseas government agencies and charitable foundations.

Journal Link: PLoS One